InvestorsHub Logo

BuddyGuise

09/09/14 9:03 AM

#125714 RE: jour_trader #125707

The pivotal study showed low and high doses to be bioequivalent, but when conducting a larger b/e study, the UAC showed bio-equivalence but not for peak concentration (Cmax)....so they did a pilot study where they determined a repeat bio-equivalence study of 32 or more should be conducted in October.....meaning, they need a bigger sample size.

inveterate

09/09/14 9:08 AM

#125717 RE: jour_trader #125707

Sharpei is a valued contributor to this board who was merely trying to assist you.